Tandem Diabetes Care (TNDM) Non Operating Income (2013 - 2026)

Tandem Diabetes Care has reported Non Operating Income for 14 years, with the latest figure at -$2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 101.73% year-over-year to -$2.4 million; the trailing twelve-month figure through Mar 2026 stood at -$14.2 million (down 465.59% YoY), and the FY2025 full-year result was -$13.0 million, down 279.34% from the prior year.
• Non Operating Income for Q1 2026 stood at -$2.4 million, up from -$3.6 million in the prior quarter.
• The five-year high for Non Operating Income was $4.2 million in Q1 2023, with the low at -$5.9 million in Q2 2025.
• Historically, Non Operating Income has averaged $280647.1 across 5 years, with a median of $598000.0 in 2024.
• Annual changes were most pronounced in 2023 — Non Operating Income soared 687.76% — and 2025, when it plunged 704.01%.
• Tandem Diabetes Care's Non Operating Income stood at $1.7 million in 2022, then surged by 125.36% to $3.8 million in 2023, then sank by 84.05% to $598000.0 in 2024, then slumped by 704.01% to -$3.6 million in 2025, then surged by 32.36% to -$2.4 million in 2026.
• The last three Non Operating Income figures came in at -$2.4 million (Q1 2026), -$3.6 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.